Table 1 Basic-line information of patients
Value (N = 20) | R&P | |
|---|---|---|
Age, years | 60 | 46–72 |
Gender | ||
Male | 13 | 65% |
Female | 7 | 35% |
TAT, days | 26 | 1–60 |
Length, cm | 2.3 ± 0.2 | 1.9–2.6 |
Diameter, cm | 1.1 ± 0.2 | 0.8–1.5 |
Therapy-related indicators | ||
WBC, 1 × 109/L | 7.0 ± 4.0 | 3.1–18.5 |
CRP, mg/L | 68.7 ± 38.0 | 13.4–170.0 |
PA, mg/L | 149.6 ± 24.6 | 105.8–185.0 |
Albumin, g/mL | 37.9 ± 3.8 | 32.6–48.0 |
Score | ||
Karnofsky | 56.5 ± 8.1 | 40.0–70.0 |
ECOG | 2.0 ± 0.7 | 1.0–3.0 |
TFC, days | 18 | 10–23 |
Sponge dressing, blocks | 6 | 3–8 |
Follow-up, days | 231 | 104–337 |
Complication | ||
Early complication | 5 | 25% |
Late complication | 8 | 40% |